Skip to main content
Caplight Logo









Fibroheal Woundcare

Fibroheal Woundcare

Private
BangaloreHealthcare & Life Scienceshttps://fibroheal.com/

Last Round

VC Round

Jul 8, 2026

Total Funding Raised

$2.04M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Fibroheal Woundcare is a biotechnology company that specializes in developing, manufacturing, and commercializing advanced wound care products derived from silk proteins.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Advanced Materials, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

wound careadvanced wound dressingsbiomaterialssilk proteinmedical deviceschronic wound managementdiabetic foot ulcer treatmentbiotech wound healingantimicrobial dressingssurgical wound carebiocompatible materialsadvanced wound caremedtechsmart bandagesregenerative medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Fibroheal Woundcare Comparables

Compare Fibroheal Woundcare with similar companies based on industry and business-model similarity.

Fibroheal Woundcare comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Serigen Mediproducts
83%
GelSana Therapeutics
76%
Axio Biosolutions
75%

Fibroheal Woundcare Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJul 8, 2026
Early FundingDec 15, 2024
Follow-on OfferingNov 29, 2022
DebtMar 17, 2022
VC RoundSep 19, 2021
Grant
Jul 30, 2019

Fibroheal Woundcare Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 24, 2026

    Monthly visitors increased 1243% MoM, reaching 16.6K.

  • Jul 30, 2025

    Added pamela Tracy, a startup in the healthcare sector.

Fibroheal Woundcare Filings

Explore SEC and related filing metadata, where available.

Fibroheal Woundcare filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Fibroheal Woundcare's valuation, stock price, and market status.

Is Fibroheal Woundcare a public or private company?

Fibroheal Woundcare is a private company.

What is the current stock price of Fibroheal Woundcare?

Fibroheal Woundcare is a private company with no public stock price. No recent secondary market data is available.

How much is Fibroheal Woundcare worth (valuation)?

Valuation information for Fibroheal Woundcare is not publicly available.

Can I buy Fibroheal Woundcare stock?

Fibroheal Woundcare shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Fibroheal Woundcare's last funding round?

Fibroheal Woundcare's most recent funding round was Pre Seed on December 15, 2024.

Who are the main investors in Fibroheal Woundcare?

Key investors in Fibroheal Woundcare include Biotechnology Industry Research Assistance Council, Karnataka Information Technology Venture Fund.

Will Fibroheal Woundcare IPO soon?

No public IPO plans have been announced for Fibroheal Woundcare.

How can I track Fibroheal Woundcare secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Fibroheal Woundcare's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBangalore
Employee Range58
Year Founded2017
Last FundingJul 8, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?